Yu-Waye Chu

(Mr. Yu-Waye Chu)

Currently holds a position at Fate Therapeutics Inc

Positions
Position Company Period
Vice President - Clinical Devel Fate Therapeutics Inc April 18, 2019 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-01-11 2023-01-10
S Sale
7,825 -5.2%
5.24
41,003 USD 		7,825 -5.2% 5.24 41,003 USD
2022-04-21 2022-04-19
S Sale
4,062 -2.6%
35.37
143,673 USD 		4,062 -2.6% 35.37 143,673 USD
2022-01-13 2022-01-11
S Sale
418 -0.3%
49.10
20,524 USD 		418 -0.3% 49.10 20,524 USD
2022-01-13 2022-01-11
S Sale
3,547 -2.8%
48.44
171,817 USD 		3,547 -2.8% 48.44 171,817 USD
2021-12-13 2021-12-10
PS Planned sale
5 -0.0%
55.54
278 USD 		5 -0.0% 55.54 278 USD
2021-12-13 2021-12-10
PS Planned sale
600 -0.5%
54.58
32,748 USD 		600 -0.5% 54.58 32,748 USD
2021-12-13 2021-12-10
PS Planned sale
1,031 -0.8%
53.66
55,323 USD 		1,031 -0.8% 53.66 55,323 USD
2021-12-13 2021-12-10
PS Planned sale
1,822 -1.4%
52.37
95,418 USD 		1,822 -1.4% 52.37 95,418 USD
2021-12-13 2021-12-10
PS Planned sale
1,045 -0.8%
51.08
53,379 USD 		1,045 -0.8% 51.08 53,379 USD
2021-12-13 2021-12-10
PS Planned sale
900 -0.7%
50.42
45,378 USD 		900 -0.7% 50.42 45,378 USD
2021-12-13 2021-12-10
PS Planned sale
2,097 -1.6%
49.32
103,424 USD 		2,097 -1.6% 49.32 103,424 USD
2021-04-20 2021-04-16
S Sale
1,500 -2.3%
84.41
126,615 USD 		1,500 -2.3% 84.41 126,615 USD
2021-04-20 2021-04-16
S Sale
900 -1.3%
82.91
74,619 USD 		900 -1.3% 82.91 74,619 USD
2021-04-20 2021-04-16
S Sale
875 -1.3%
81.80
71,575 USD 		875 -1.3% 81.80 71,575 USD